Raymond James & Associates Coh Bar, Inc. Transaction History

Raymond James & Associates

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.17 - $0.34 $3,600 - $7,201	-21,180 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$0.25 - $0.43 $810 - $1,393	-3,240 Reduced 13.27%	21,180 $7,000
Q2 2021 Aug 11, 2021	BUY	$1.09 - $1.49 $2,496 - $3,412	2,290 Added 10.35%	24,420 $34,000
Q1 2021 May 14, 2021	BUY	$1.26 - $2.02 $2,570 - $4,120	2,040 Added 10.15%	22,130 $30,000
Q4 2020 Feb 12, 2021	BUY	$0.9 - $1.54 $18,081 - $30,938	20,090 New	20,090 $27,000

1.14K

Ticker CWBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,906,940
Market Cap $1.57M
Description
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.